These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38871630)

  • 1. Psychedelics and Older Adults: What Do They Do Compared to Younger People?
    Harvey PD
    Am J Geriatr Psychiatry; 2024 Jun; ():. PubMed ID: 38871630
    [No Abstract]   [Full Text] [Related]  

  • 2. The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.
    Johnston CB; Mangini M; Grob C; Anderson B
    Am J Geriatr Psychiatry; 2023 Jan; 31(1):44-53. PubMed ID: 36184377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of psychedelics in the Czech Republic: results of recent population surveys.
    Chomynová P; Kočárová R; Kňažek F; Plevková M; Bláhová B; Valeš K; Mravčík V
    Cent Eur J Public Health; 2022 Sep; 30(3):144-153. PubMed ID: 36239361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.
    Kruger DJ; Enghoff O; Herberholz M; Barron J; Boehnke KF
    J Psychoactive Drugs; 2023; 55(5):631-639. PubMed ID: 37078418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers.
    Boehnke KF; Cox K; Weston C; Herberholz M; Glynos N; Kolbman N; Fields CW; Barron J; Kruger DJ
    Front Psychiatry; 2023; 14():1224551. PubMed ID: 37599880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a new instrument for assessing attitudes on psychedelics in the general population.
    Žuljević MF; Buljan I; Leskur M; Kaliterna M; Hren D; Duplančić D
    Sci Rep; 2022 Oct; 12(1):18225. PubMed ID: 36309539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.
    Kruger DJ; Glynos NG; Fields CW; Herberholz M; Boehnke KF
    J Psychoactive Drugs; 2023; 55(4):420-424. PubMed ID: 36328419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and epidemiological associates of novel psychedelic use in the United States adult population.
    Sexton JD; Crawford MS; Sweat NW; Varley A; Green EE; Hendricks PS
    J Psychopharmacol; 2019 Sep; 33(9):1058-1067. PubMed ID: 30816808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between naturalistic use of psychedelics and co-occurring substance use disorders.
    Rabinowitz J; Lev-Ran S; Gross R
    Front Psychiatry; 2022; 13():1066369. PubMed ID: 36704738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey.
    Evens R; Reiche S; Marek RM; Moon DU; Groß RE; Romanello A; Jalilzadeh Masah D; Scicchitano Böckheler M; Gutwinski S; Montag C; Mick I; Majić T
    Front Psychiatry; 2021; 12():732028. PubMed ID: 34803757
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychedelics and mental health: a population study.
    Krebs TS; Johansen PØ
    PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.
    Phan AN; Terry GE
    Front Psychiatry; 2023; 14():1144276. PubMed ID: 37435402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between the use of psychedelics and other recreational drugs with mental health and resilience during the COVID-19 pandemic.
    Bălăeț M; Trender W; Hellyer PJ; Hampshire A
    Front Psychiatry; 2023; 14():1184681. PubMed ID: 37398594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the Protective Strategies for Psychedelics Scale: A novel inventory to assess safety strategies in the context of psychedelics.
    Mian MN; Altman BR; Low F; Earleywine M
    J Psychopharmacol; 2024 Jan; 38(1):101-109. PubMed ID: 38050326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards an understanding of psychedelic-induced neuroplasticity.
    Calder AE; Hasler G
    Neuropsychopharmacology; 2023 Jan; 48(1):104-112. PubMed ID: 36123427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.
    Bonnelle V; Smith WJ; Mason NL; Cavarra M; Kryskow P; Kuypers KP; Ramaekers JG; Feilding A
    Br J Pain; 2022 Dec; 16(6):619-631. PubMed ID: 36452124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older adults are not more susceptible to acute muscle atrophy after immobilisation compared to younger adults: a systematic review.
    Hodgson H; Wilkinson M; Bowen S; Giannoudis P; Howard A
    Eur J Trauma Emerg Surg; 2022 Apr; 48(2):1167-1176. PubMed ID: 34081160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation.
    Cheung K; Patch K; Earp BD; Yaden DB
    Camb Q Healthc Ethics; 2023 Jun; ():1-7. PubMed ID: 37366110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the Top-Cited Articles on Classic Psychedelics.
    Lawrence DW; Sharma B; Griffiths RR; Carhart-Harris R
    J Psychoactive Drugs; 2021; 53(4):283-298. PubMed ID: 33535907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.